Sun.Feb 12, 2023

article thumbnail

Centre notifies Rules for CCSEA with provisions for deemed approval & grading of animal house facilities

AuroBlog - Aurous Healthcare Clinical Trials blog

The Central government has notified the administrative Rules for the Committee for Control and Supervision of Experiments on Animals (CCSEA), the statutory Committee to regulate and monitor experiments on animals to prevent cruelty to animals, with provisions for deemed approval and grading of animal house facilities in medical colleges, pharmacy colleges, pharma and vaccine industry, […]

Pharmacy 151
article thumbnail

Is chocolate good for your heart? Finally the FDA has an answer – kind of

NPR Health - Shots

For years, chocolate-lovers have pointed to studies suggesting compounds in cocoa may be good for heart health.

140
140
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A Splash of Milk in Coffee May Have Health Benefits We Didn’t Know About

AuroBlog - Aurous Healthcare Clinical Trials blog

It’s no secret that coffee brings joy to people all over the world. It warms the soul, provides a focus boost, and brings people together, not to mention that it smells and tastes heavenly.

article thumbnail

Clinical Trial Regulations in the United States

ProRelix Research

Historical events such as the sulfanilamide elixir tragedy that resulted in the mass poisoning and the deaths of hundreds of patients in the 1930s and the thalidomide scandal which caused […] The post Clinical Trial Regulations in the United States appeared first on ProRelix Research.

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Study suggests that wildfire smoke increases risk of going into labor prematurely

Medical Xpress

In a new study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting—and published in the American Journal of Obstetrics and Gynecology—researchers will unveil findings that suggest that being exposed to another type of and potentially more dangerous pollutant ― smoke from wildfires ― increases a pregnant person's chance of going into labor prematurely, also referred to as spontaneous preterm birth (versus one that is medically induced).

article thumbnail

Hospitals contracted with private companies are cutting costs by relying on nurses

NPR Health - Shots

More and more hospitals are contracting with private companies to run their emergency departments. To save money, many are increasingly relying on nurses and physician assistants instead of doctors.

Nurses 89

More Trending

article thumbnail

The Medical Metaverse Monthly Digest

Intouch Solutions

The “nextmakers” of EVERSANA INTOUCH know the medical metaverse is changing everything, whether you’re a patient, a provider, a caregiver — or a brand marketer. We scour the world for the latest on the metaverse in healthcare, and update you regularly on what you need to know.  Can the metaverse help you donate blood? Abbott Unveils “Mixed Reality” Experience for Blood Donors as it Looks to Boost Younger People’s Awareness (FiercePharma.com) – Abbott and the Blood Centers of America have

Nurses 59
article thumbnail

FDA Approval of Drugs Not Meeting Pivotal Trial Primary End Points

JAMA Internal Medicine

This cross-sectional study determines the frequency of and rationale for US Food and Drug Administration (FDA) approval of drugs not meeting pivotal trial primary efficacy end points.

article thumbnail

New patent expiration for Indivior Inc drug SUBOXONE

Drug Patent Watch

Annual Drug Patent Expirations for SUBOXONE Suboxone is a drug marketed by Indivior Inc and is included in two NDAs. It is available from one supplier. There are eight patents… The post New patent expiration for Indivior Inc drug SUBOXONE appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

FDA-Approved Drugs Not Recommended for Use or Reimbursement in Other Countries, 2017-2020

JAMA Internal Medicine

This cross-sectional study evaluates regulatory decisions and health technology assessments in Australia, Canada, and the UK regarding new drugs approved by the US Food and Drug Administration in 2017 through 2020, as well as estimates the US cost per patient per year for drugs receiving negative recommendations.

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Which pharmaceutical drugs have the most drug patents in European Patent Office?

Drug Patent Watch

This chart shows the drugs with the most patents in European Patent Office. Patents must be filed in each country (or, in some cases regional patent office) where patent protection… The post Which pharmaceutical drugs have the most drug patents in European Patent Office? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 40
article thumbnail

The Canadian Drug Importation Rule Survives Industry Challenge, But Don’t Expect Canadian Drugs at Your Pharmacy Just Yet

FDA Law Blog

By Faraz Siddiqui — In November of 2020, plaintiffs representing the pharmaceutical industry sued the U.S. Department of Health and Human Services (HHS) to block a rule that would allow the importation of Canadian prescription drugs (see our blog post on the complaint). Last week, the D.C. District Court dismissed the suit for lack of standing because plaintiffs could not show any concrete risk of harm.